Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01569646 · ClinicalTrials.gov registry record
Monocytosis and Culprit Vessel in STEMI Patients
A clinical trial, sponsored by Northwell Health.
- Completed
- Registry status
- 226
- Enrollment target
NCT01569646 is a clinical trial that has completed, run by Northwell Health. The registered enrollment target is 226 participants.
The verdict
NCT01569646 has completed, sponsored by Northwell Health.
- COMPLETED
- Registry status
- 226 participants
- Enrollment target
Study Summary
Increased white blood cell count at the onset of an acute ST elevation myocardial infarction has been shown to be associated of increased incidence of heart failure and mortality. Now monocytes which are a subset of white blood cells may have a prognostic value for patients presenting with acute ST segment elevation myocardial infarction. A monocyte count of greater than 800/mm3 following acute myocardial infarction has been shown to be associated with increased incidence of left ventricular dysfunction. The investigators study would retrospectively collect data on patients with ST elevation myocardial infarction, looking for an association between high monocyte count and the culprit vessel causing the myocardial infarction. The investigators would also investigate whether monocytosis would be a marker of poor prognosis.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 226 participants |
| Start Date | 2008-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01569646
The ClinicalTrials.gov registry entry for NCT01569646 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 226 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01569646 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01569646 about?
NCT01569646 is a clinical study titled "Monocytosis and Culprit Vessel in STEMI Patients". Increased white blood cell count at the onset of an acute ST elevation myocardial infarction has been shown to be associated of increased incidence of heart failure and mortality. Now monocytes which are a subset of white blood cells may have a prognostic value for patients presenting with acute ST ...
What is the current status of trial NCT01569646?
This trial is currently completed. The enrollment target is 226 participants. The study started on 2008-04.
Who is sponsoring clinical trial NCT01569646?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.